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Introduction 
Over 85% of cancer patients nationwide receive care in the community setting 
(NCI, 2007).  In 2008, the Midwest Cancer Alliance (MCA) launched with a vision 
of marshaling the exceptional cancer resources of the region to support the 
system of care provided to patients while keeping them “close to home”. With an 
emphasis on education and research, the MCA was developed to connect 
hospitals and physician groups across Kansas and western Missouri with the 
purpose of:  
• Providing strong support to community cancer care professionals;  
• Enhancing cancer care for patients across the region;  
• Advancing access to innovative, investigator-initiated and cooperative 
group clinical trials; 
• Advancing access to newly developed therapies and prevention 
strategies;  
• Providing continuing professional and community education opportunities;  
• Facilitating second opinion and consultation services; and 
• Providing patient navigator technical assistance across the network. 
A membership-based organization, the MCA currently has 14 partners spanning 
the region including:  
• Children’s Mercy Hospital and Clinics 
• Goodland Regional Medical Center 
• Hays Medical Center 
• Kansas Bioscience Authority 
• Kansas State University  
• Mt. Carmel Regional Medical Center 
• Promise Regional Medical Center 
• Saint Luke’s Health System 
• Salina Regional Health Center 
• St. Francis Health Center 
• Stormont-Vail HealthCare 
• Stowers Institute for Medical Research 
• Truman Medical Center 
• The University of Kansas Hospital 
 
Methods 
In collaboration with members, the MCA facilitates a wide-array of cancer related 
services.  Activities range from developing clinical trial infrastructure including, a 
centralized Institutional Review Board (IRB), online Velos clinical trials 
management software to facilitate enrollment and trial data management, and 
access to Southwest Oncology Group (SWOG), Clinical Trials Support Unit 
(CTSU) sponsored trials, and research initiated by The University of Kansas 
Cancer Center’s Investigators.  
MCA provides professional and community education specific to the needs of the 
community. Members have access to The University of Kansas Cancer Center 
Tumor Boards as well as continuing education such as chemotherapy and 
oncology nurse certification curricula.   
Results 
Numerous cancer-related activities have occurred since the inception of the 
MCA.   
 
• Over 11,450 individuals attended MCA community education and 
screening events.  
• 6,200 cancer screenings resulted in 470+ referrals back to local 
physicians for follow-up on abnormal results. 
• Over 3,096 Continuing Nursing Education (CNE) credits and 296 
Continuing Medical Education (CME) credits.  
• Five members have capacity to enroll patients through MCA sponsored 
trials with access to SWOG and CTSU. 
• 7 cases have been presented at tumor boards. 
• 9 second opinion consultations occurred through the use of telemedicine 
technology. 
Discussion 
Less than three percent of adult cancer patients participate in clinical trials 
(Christian & Trimble, 2003). The MCA was established, in part, to address 
disparities such as this, in an effort to enhance the excellent cancer care 
provided across the region. The MCA appears to hold great promise of achieving 
this vision, by leveraging region’s collective cancer resources and cancer 
expertise. 
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